Active B12 Test Market Size

Market Size Snapshot

Note – Market size depicts the revenue generated over the financial year

The active vitamin B12 test is a major growth market, with the current market size of $ 4,621,000, projected to reach $ 17,941,000 by 2034. This remarkable growth represents a CAGR of 16.26% from 2025 to 2034. The increasing frequency of B12 deficiency and the growing awareness of its health consequences have fueled the demand for accurate diagnostics. The development of new testing methods and advances in laboratory technology are also expected to drive growth. Several of the major players in the active B12 test market, such as Siemens, Roche, and Abbott Laboratories, are investing in research and development to enhance their product offerings. Strategic initiatives, such as strategic alliances and collaborations, aimed at expanding market reach and improving test accuracy, are also expected to drive growth. Recent product launches, which feature advanced testing technology, are expected to meet the growing demand for accurate and fast diagnostics and further boost market growth.

Regional Market Size

Regional Deep Dive

The Active B12 test market is growing strongly in many regions, driven by a growing awareness of vitamin B12 deficiency and its health consequences. In North America, the market is characterized by an advanced health care system and high diagnostic testing rates. In Europe, on the other hand, there is a strong focus on preventive health care and a greater nutritional awareness. In the Asia-Pacific region, the market is growing rapidly due to rising health care expenditure and a growing population. Middle Eastern and African countries are gradually developing their health care systems, which will lead to an increase in diagnostic testing. Latin America is focusing on access to health care and raising awareness of vitamin deficiencies.

Europe

• The European Union has implemented stricter regulations on nutritional supplements, which has led to increased awareness and testing for vitamin deficiencies, including B12, thereby driving the market.
• Organizations such as the European Society for Clinical Nutrition and Metabolism (ESPEN) are promoting guidelines that emphasize the importance of monitoring vitamin B12 levels, influencing healthcare providers to adopt Active B12 testing.

Asia Pacific

• Countries like Japan and Australia are investing in advanced diagnostic technologies, with companies like Roche Diagnostics introducing innovative Active B12 testing solutions that cater to the growing health-conscious population.
• The rise of telemedicine in countries such as India is facilitating easier access to diagnostic tests, including Active B12 tests, thereby expanding the market reach.

Latin America

• Governments in Brazil and Mexico are implementing public health campaigns to address vitamin deficiencies, which is leading to increased demand for Active B12 testing in healthcare facilities.
• Partnerships between local laboratories and global diagnostic companies are emerging, aimed at improving the accessibility and affordability of Active B12 tests in underserved areas.

North America

• The U.S. Food and Drug Administration (FDA) has recently approved new testing methodologies for vitamin B12 levels, enhancing the accuracy and reliability of Active B12 tests, which is expected to boost market adoption.
• Key players like Quest Diagnostics and LabCorp are expanding their testing services to include Active B12 tests, responding to the growing demand for comprehensive nutritional assessments.

Middle East And Africa

• The World Health Organization (WHO) has launched initiatives aimed at improving nutritional health in the region, which includes increasing awareness and testing for vitamin deficiencies like B12.
• Local companies are beginning to collaborate with international firms to enhance the availability of Active B12 tests, reflecting a growing recognition of the importance of nutritional diagnostics.

Did You Know?

“Studies indicate that nearly 40% of the global population may be at risk of vitamin B12 deficiency, highlighting the critical need for effective testing and diagnosis.” — World Health Organization (WHO)

Segmental Market Size

B12 test market is a growing part of the diagnostics market, driven by an increasing awareness of B12 deficiency and its health consequences. The increasing prevalence of diseases such as pernicious anemia and neuropathy caused by B12 deficiency, the increasing focus on preventive medicine and the growing importance of early diagnosis, are the main drivers of the market. Further, the development of diagnostics increases the accuracy and availability of these tests, further increasing the market interest. B12 tests are currently being commercialized, with Quest and LabCorp being the first to offer these specialized tests. These tests are primarily used in clinical settings for the diagnosis of B12 deficiency in patients with neuropathy or anemia. The market is further accelerated by the government's initiatives to increase screening and preventive medicine. The market is further shaped by the development of high-performance liquid chromatography (HPLC) and ELISA, which ensures precise measurement of B12 levels in patients.

Future Outlook

In the period 2026 to 2034, the active vitamin B12 test market is expected to grow from a value of $ 4.62 billion to $17.94 billion, with a robust compound annual growth rate (CAGR) of 16.26%. The growth is driven by the growing awareness of the risk of vitamin B12 deficiency and its consequences, especially in the elderly population and in people with special dietary needs. It is expected that the penetration of active B12 testing will increase significantly, with the penetration of the active B12 test reaching more than 30% in the high-risk groups by 2034, compared to the current estimate of about 15%. Several technological advances, such as the development of more sensitive and rapid test methods, will increase the accuracy and availability of active B12 testing. Also, supportive health policies that promote preventive care and nutritional awareness will further drive the market. In addition, telemedicine and personalization of medicine will facilitate the widespread use of these tests, enabling timely interventions and improved patient outcomes. These market developments will continue to evolve, and the market participants will have to keep up with these developments to seize the expanding opportunities in the active B12 test market.